Colonic Drug Targeting
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Specific targeting of drugs to the colon is recognized to have several therapeutic advantages. Drugs which are destroyed by the stomach acid and/or metabolized by pancreatic enzymes are slightly affected in the colon, and sustained colonic release of drugs can be useful in the treatment of nocturnal asthma, angina and arthritis. Treatment of colonic diseases such as ulcerative colitis, colorectal cancer and Crohn's disease is more effective with direct delivery of drugs to the affected area. Likewise, colonic delivery of vermicides and colonic diagnostic agents require smaller doses. This article is aimed at providing insight into the design considerations and evaluation of colonic drug delivery systems. For this purpose, the anatomy and physiology of the lower gastrointestinal tract are surveyed. Furthermore, the biopharmaceutical aspects are considered in relation to drug absorption in the colon and hence various approaches to colon-specific drug delivery are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of gastrointestinal pH profiles in normal ambulant human subjects
Evans, D. F., Pye, G., Bramley, R., Clark, A. G., Dyson, T. J., & Hardcastle, J. D. (1988) · Gut · doi:10.1136/gut.29.8.1035 · Cited by 1,240
Molly, K., Vande Woestyne, M., & Verstraete, W. (1993) · Applied Microbiology and Biotechnology · doi:10.1007/bf00228615 · Cited by 672
Contribution of the microflora to proteolysis in the human large intestine
Macfarlane, G. T., Allison, C., Gibson, S. A. W., & Cummings, J. H. (1988) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1988.tb02427.x · Cited by 237
Factors Affecting Metabolic Activity of the Intestinal Microflora
Rowland, I. R. (1988) · Drug Metabolism Reviews · doi:10.3109/03602538808994135 · Cited by 84
Simonsen, L., Hovgaard, L., Mortensen, P. B., & Brøndsted, H. (1995) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(95)00023-6 · Cited by 75
Cited by
Polysaccharides in colon-specific drug delivery
Sinha, V. R., & Kumria, R. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00720-7 · Cited by 872
Encapsulation for preservation of functionality and targeted delivery of bioactive food components
de Vos, P., Faas, M. M., Spasojevic, M., & Sikkema, J. (2010) · International Dairy Journal · doi:10.1016/j.idairyj.2009.11.008 · Cited by 786
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation
Yang, L., Chu, J. S., & Fix, J. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00004-2 · Cited by 562
Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
Lamprecht, A., Schäfer, U., & Lehr, C.-M. (2001) · Pharmaceutical Research · doi:10.1023/a:1011032328064 · Cited by 507
Biodegradable Nanoparticles for Targeted Drug Delivery in Treatment of Inflammatory Bowel Disease
Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Maincent, P., Kawashima, Y., & Lehr, C.-M. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29290-9 · Cited by 403
Metadata
- Authors
- Kinget, R., Kalala, W., Vervoort, L., & van den Mooter, G.
- Venue
- Journal of Drug Targeting
- Publisher
- Informa UK Limited
- Published
- 1998-01
- Volume
- 6
- Issue
- 2
- Pages
- 129-149
- ISSN
- 1026-7158 (ISSN-L)
- 1061-186X
- 1029-2330
- OpenAlex
- W2132545697
- Cited by
- 194
- References
- 5
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Colonic Drug Targeting. https://app.cochat.ai/papers/10.3109/10611869808997888
- The paper
- Kinget, R., Kalala, W., Vervoort, L., & van den Mooter, G. (1998). Colonic Drug Targeting. Journal of Drug Targeting. https://doi.org/10.3109/10611869808997888
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.